TARIS Biomedical Inc. is a specialty pharmaceutical company focused on local minimally-invasive drug-device convergence products. TARIS core technology and development efforts are focused on high unmet need disease areas in which current therapies or systemic treatments have failed. TARIS Biomedical has several drug-device convergence program opportunities.

Ed Kania is on the Board of Directors.